Hitachi, Ltd. initially announced in a Dec. 18, 2019, press release that it has executed an absorption-type split involving its diagnostic imaging-related business and its consolidated subsidiaries and affiliate companies, through which the business will be transferred to a newly established company serving as a successor company and transfer all shares in the new company to FUJIFILM Corporation after the company split.
Initially, Hitachi and Fujifilm scheduled the effective date for the company split above and closing date of the share transfer on July 1, 2020. However, because of delays in preparations for the transaction due to the global spread of novel coronavirus (COVID-19), Hitachi and Fujifilm agreed to change the execution date. The new execution date has not yet been determined and will be promptly given as soon as it is available.
Back To Top
Hitachi to Issue $1 Million in Loans Through Kiva Businesses Affected by COVID-19
Hitachi, Ltd. announced on May 18 that it will make a...
FUJIFILM, Sun Nuclear Partner to Raise Breast Cancer Awareness
FUJIFILM Medical Systems U.S.A., Inc., a provider of diagnostic...
Fujifilm Announces New Solution for Medical Image Capture, Management
FUJIFILM Corporation, a multinational imaging and informatics...
Hitachi Healthcare Americas to build R&D center in Twinsburg, Ohio
Hitachi Healthcare Americas will create a new dedicated research...
Hitachi, Fujifilm Postpone Company Split . Appl Radiol.
